Deep dissection of stemness-related hierarchies in hepatocellular carcinoma

被引:4
|
作者
Liang, Rui [1 ]
Hong, Weifeng [2 ]
Zhang, Yang [3 ]
Ma, Di [1 ]
Li, Jinwei [4 ]
Shi, Yisong [1 ]
Luo, Qing [1 ]
Du, Shisuo [2 ]
Song, Guanbin [1 ]
机构
[1] Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400030, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Radiat Oncol, 180 Fenglin Rd, Shanghai, Peoples R China
[3] Dali Univ, Affiliated Hosp 1, Gen Surg 1, Dali 671000, Peoples R China
[4] Guangxi Med Univ, Dept Neurosurg, Affiliated Hosp 4, Liuzhou 545000, Guangxi, Peoples R China
关键词
Hepatocellular carcinomas; Stemness; Molecule subtypes; Prognosis; Tumor microenvironment; Immunotherapy; Immune infiltration; mRNAsi; scRNA-seq; LPCAT1; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 1; CANCER; CELLS; PROGRESSION; EVOLUTION; HALLMARK; GROWTH; ATLAS; NICHE;
D O I
10.1186/s12967-023-04425-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundIncreasing evidence suggests that hepatocellular carcinoma (HCC) stem cells (LCSCs) play an essential part in HCC recurrence, metastasis, and chemotherapy and radiotherapy resistance. Multiple studies have demonstrated that stemness-related genes facilitate the progression of tumors. However, the mechanism by which stemness-related genes contribute to HCC is not well understood. Here, we aim to construct a stemness-related score (SRscores) model for deeper analysis of stemness-related genes, assisting with the prognosis and individualized treatment of HCC patients.Further, we found that the gene LPCAT1 was highly expressed in tumor tissues by immunohistochemistry, and sphere-forming assay revealed that knockdown of LPCAT1 inhibited the sphere-forming ability of hepatocellular carcinoma cells.MethodsWe used the TCGA-LIHC dataset to screen stemness-related genes of HCC from the MSigDB database. Prognosis, tumor microenvironment, immunological checkpoints, tumor immune dysfunction, rejection, treatment sensitivity, and putative biological pathways were examined. Random forest created the SRscores model. The anti-PD-1/anti-CTLA4 immunotherapy, tumor mutational burden, medication sensitivity, and cancer stem cell index were compared between the high- and low-risk score groups. We also examined risk scores for different cell types using single-cell RNA sequencing data and correlated transcription factor activity in cancer stem cells with SRscores genes. Finally, we tested core marker expression and biological functions.ResultsPatients can be divided into two subtypes (Cluster1 and Cluster2) based on the TCGA-LIHC dataset's identification of 11 stemness-related genes. Additionally, a SRscores was developed based on subtypes. Cluster2 and the group with the lowest SRscores had superior survival and immunotherapy response than Cluster1 and the group with the highest SRscores. The group with a high SRscores was significantly more enriched in classical tumor pathways than the group with a low SRscores. Multiple transcription factors and SRscores genes are correlated. The core gene LPCAT1 is highly expressed in rat liver cancer tissues and promotes tumor cell sphere formation.ConclusionA SRscores model can be utilized to predict the prognosis of HCC patients as well as their response to immunotherapy.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer
    Fu, Shi
    Tan, Zhiyong
    Shi, Hongjin
    Chen, Junhao
    Zhang, Yawei
    Guo, Chunming
    Feng, Wei
    Xu, Haole
    Wang, Jiansong
    Wang, Haifeng
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [42] A bioinformatics analysis to evaluate the prognostic value of stemness-related genes in gastric cancer
    Lu, Yu-Jie
    Lian, Lian
    Shen, Xiao-Ming
    Li, Ying
    Ji, Sheng-Jun
    Wang, Wen-Jie
    Yang, Yi
    Wang, Ying
    Duan, Wei-Ming
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (01) : 174 - +
  • [43] Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer
    Shi Fu
    Zhiyong Tan
    Hongjin Shi
    Junhao Chen
    Yawei Zhang
    Chunming Guo
    Wei Feng
    Haole Xu
    Jiansong Wang
    Haifeng Wang
    npj Precision Oncology, 8
  • [44] Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer
    Quan Jiang
    Hao Chen
    Zhaoqing Tang
    Jie Sun
    Yuanyuan Ruan
    Fenglin Liu
    Yihong Sun
    BMC Cancer, 21
  • [45] A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma
    Huang, Xiao-Yan
    Qin, Wen-Tao
    Su, Qi-Sheng
    Qiu, Cheng-Cheng
    Liu, Ruo-Chuan
    Xie, Shan-Shan
    Hu, Yang
    Zhu, Shang-Yong
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [46] Clinical application and immune infiltration landscape of stemness-related genes in heart failure
    Yan, Wenting
    Li, Yanling
    Wang, Gang
    Huang, Yuan
    Xie, Ping
    ESC HEART FAILURE, 2025, 12 (01): : 250 - 270
  • [47] A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma
    Wang, Wei
    Xu, Congrong
    Ren, Yan
    Wang, Shiwei
    Liao, Chunli
    Fu, Xiaoyan
    Hu, Haixia
    STEM CELLS INTERNATIONAL, 2021, 2021
  • [48] TARGETING TGF-BETA I WITH THE TRANSFORMING GROWTH FACTOR RECEPTOR TYPE I KINASE INHIBITOR, LY2157299, MODULATES STEMNESS-RELATED BIOMARKERS IN HEPATOCELLULAR CARCINOMA
    Rani, B.
    Dituri, F.
    Cao, Y.
    Engstrom, U.
    Lupo, L.
    Dooley, S.
    Moustakas, A.
    Giannelli, G.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S429 - S429
  • [49] Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer
    Jiang, Quan
    Chen, Hao
    Tang, Zhaoqing
    Sun, Jie
    Ruan, Yuanyuan
    Liu, Fenglin
    Sun, Yihong
    BMC CANCER, 2021, 21 (01)
  • [50] Stemness-related gene signature for predicting therapeutic response in patients with esophageal cancer
    Zhu, Shaojin
    Zhang, Gengxin
    You, Qi
    Li, Fei
    Ding, Boying
    Liu, Feng
    Bi, De
    Jiang, Lan
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (07) : 2359 - +